Clinical Trials Logo
  1. Home
  2. Chronic Stable Heart Failure
  3. NCT00664222

Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

Chronic Stable Heart Failure Clinical Trial

Official title:
Effects of Spironolactone on Insulin Resistance in Patients With Chronic Heart Failure

Clinical Trial Summary

The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.

Clinical Trial Description

Diuretics is useful in CHF patients. On the other hand, they deteriorate glucose metabolism. Therefore, the purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00664222
Study type Interventional
Source Tottori University Hospital
Contact
Status Completed
Phase Phase 4
Start date January 2004
Completion date December 2005
View Details
See also
  Status Clinical Trial Phase
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Completed NCT02696967 - A Study of CLR325 in Chronic Stable Heart Failure Patients. Phase 2
Recruiting NCT03834155 - Enhancing Cardiac Rehabilitation Through Behavioral Nudges N/A
Withdrawn NCT04507347 - Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus Phase 3
Completed NCT02204449 - Cardiac Rehabilitation Peer Mentorship N/A
Completed NCT00663195 - Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure Phase 4
Completed NCT00663494 - Matrix Metalloproteinase (MMP) in Heart Failure N/A
Recruiting NCT05034549 - Noninvasive Ventilation for Chronic Heart Failure N/A
Recruiting NCT01065194 - Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure Phase 3